Regulatory

6 Considerations for Developing Modified Release Versions of Immediate Release Oral Solid Dosage Forms

By Richard Sidwell, Ph.D., Senior Vice President and Chief Scientific Officer, and Wayne Wiley, RPh, Vice President, Regulatory Affairs and Pharmacovigilance | September 10, 2020

Regulatory and CMC Strategy Key for Extended and Controlled Release Products Developing a modified release (MR) formulation of an existing…

Read More

Topics: Modified Release, Oral Solid Dosage, Regulatory